TrialClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2007

Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection.

A A Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.